Dopamine D1 receptor activation induces tau phosphorylation via cdk5 and GSK3 signaling pathways.
about
Apomorphine treatment in Alzheimer mice promoting amyloid-β degradationRegulation of tyrosine phosphatase STEP61 by protein kinase A during motor skill learning in miceMitochondrial dysfunction driven by the LRRK2-mediated pathway is associated with loss of Purkinje cells and motor coordination deficits in diabetic rat model.Maladaptive striatal plasticity in L-DOPA-induced dyskinesia.γ-Aminobutyric acid type A (GABAA) receptor activation modulates tau phosphorylation.Tau, prions and Aβ: the triad of neurodegeneration.Levodopa/benserazide microsphere (LBM) prevents L-dopa induced dyskinesia by inactivation of the DR1/PKA/P-tau pathway in 6-OHDA-lesioned Parkinson's rats.Quantitative expression analysis of APP pathway and tau phosphorylation-related genes in the ICV STZ-induced non-human primate model of sporadic Alzheimer's disease.Therapeutic strategies in fragile X syndrome: dysregulated mGluR signaling and beyond.Proteolytic regulation of the mitochondrial cAMP-dependent protein kinase.Lovastatin protects neurite degeneration in LRRK2-G2019S parkinsonism through activating the Akt/Nrf pathway and inhibiting GSK3β activity.Ryanodine receptor blockade reduces amyloid-β load and memory impairments in Tg2576 mouse model of Alzheimer disease.Inhibition of Glycogen Synthase Kinase-3β (GSK-3β) as potent therapeutic strategy to ameliorates L-dopa-induced dyskinesia in 6-OHDA parkinsonian rats.Traditional Chinese Medicine Huannao Yicong Decoction Extract Decreases Tau Hyperphosphorylation in the Brain of Alzheimer's Disease Model Rats Induced by Aβ1-42.Mediators of tau phosphorylation in the pathogenesis of Alzheimer's disease.Dopamine D1 receptors, regulation of gene expression in the brain, and neurodegeneration.Interaction between pathogenic proteins in neurodegenerative disorders.Neuroglialpharmacology: myelination as a shared mechanism of action of psychotropic treatments.Glycogen synthase kinase 3 beta (GSK3β) at the tip of neuronal development and regeneration.Off the beaten track: the molecular structure of long-term memory: three novel hypotheses-electrical, chemical and anatomical (allosteric).Regulation of synaptic transmission at the photoreceptor terminal: a novel role for the cation-chloride co-transporter NKCC1.Dopa Decarboxylase Modulates Tau Toxicity.Hippocampal glycogen synthase kinase 3β is critical for the antidepressant effect of cyclin-dependent kinase 5 inhibitor in rats.Altered subcellular distribution of the 75-kDa DISC1 isoform, cAMP accumulation, and decreased neuronal migration in schizophrenia and bipolar disorder: implications for neurodevelopment.Interaction between α-synuclein and other proteins in neurodegenerative disorders.The human brainome: network analysis identifies HSPA2 as a novel Alzheimer’s disease target
P2860
Q28306851-1E7CA671-407D-4CA9-98F8-1FB28B298FB2Q28394767-3E76A99E-C0BF-485B-B1BA-3E1C24ACA1EDQ33720211-729C2288-0283-4F06-A037-096087944B82Q34094008-8831F802-C6D8-4688-ADBE-30615337F6BAQ34123407-69E5E36A-17A0-4B6A-A703-1ED8BE3716BAQ34463061-FC275D83-1C42-4923-B5AD-2617D01563A5Q34708186-BB8D2397-E3DC-49B0-8E2C-3D9103D28A73Q35138870-75A06022-BDF0-451E-92C0-22268C5E731CQ35614072-E3430EE9-BF9F-456B-AF4B-727C9B4BCD66Q35843116-7EC36CFE-6991-41DB-A88F-D77C5D1AA0D7Q35941717-A301052F-EF4A-4F01-8624-54B203373324Q36279483-77B9E160-FB3F-4282-AF3F-5D6F16CAD9CAQ36708392-1471E5CA-2D03-4206-92BE-12CC34C1AE9BQ37497045-95151975-9B9C-46A0-ACAE-907B2D407B05Q37630546-DEFE73F8-97BE-4158-B968-54633C00CD9AQ37772934-B67F36D4-D5A7-4503-92F4-5F56AC0760D1Q37969262-A11512B6-BA52-43DE-91B7-F32D18DD3A52Q37981491-21983650-CA2A-4D41-BE07-23C391FA9A5AQ38155462-E66B4654-86B6-44D9-92B5-EEF6C936FBC5Q43123016-A08554DD-E553-4A16-9925-4C6615CC66F4Q43977602-BF8177BF-0A6B-4885-ABBA-1E4DCCAC8FDEQ47659329-4A4680ED-4284-4784-B7F3-806AE920A494Q48346810-5A6ED98A-FC7D-4483-B5ED-6E1D2059140FQ48361051-10A74DDD-926F-4A48-B9DA-048D87D7DAD1Q53324250-E0F3AED4-4CF7-4243-A4D5-385F5EC69D81Q58733550-9AB5F1B6-B933-42E5-8E0F-409D469CE807
P2860
Dopamine D1 receptor activation induces tau phosphorylation via cdk5 and GSK3 signaling pathways.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Dopamine D1 receptor activatio ...... 5 and GSK3 signaling pathways.
@en
Dopamine D1 receptor activatio ...... 5 and GSK3 signaling pathways.
@nl
type
label
Dopamine D1 receptor activatio ...... 5 and GSK3 signaling pathways.
@en
Dopamine D1 receptor activatio ...... 5 and GSK3 signaling pathways.
@nl
prefLabel
Dopamine D1 receptor activatio ...... 5 and GSK3 signaling pathways.
@en
Dopamine D1 receptor activatio ...... 5 and GSK3 signaling pathways.
@nl
P2093
P1433
P1476
Dopamine D1 receptor activatio ...... 5 and GSK3 signaling pathways.
@en
P2093
Christian Patenaude
Guy Massicotte
Julie Allyson
Manon Lebel
Michel Cyr
P304
P356
10.1016/J.NEUROPHARM.2009.06.041
P577
2009-07-08T00:00:00Z